• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10 Orthopedic Device Firms
    • Buyers' Guide
    • Events
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10 Orthopedic Device Firms
  • Buyers' Guide
  • Events
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    Top Features
    From Nitinol to Nanotubes: A Materials Science Roundtable

    In Good Repair: Trauma Technologies Under Review

    Anxious Undertones: A Review of 2019

    Automated Analysis Advantages for Part Validation

    Tried and True Metalworking
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    TriMed Closes Out FDA Warning Letter

    FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System

    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application

    Tyber Medical Opens $8M Office and Manufacturing Facility

    FDA OKs Shoulder Surgery 3D Planner & Positioner
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    TriMed Closes Out FDA Warning Letter

    Sounding Board: Looking Back at 2019 and Gazing at 2020

    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application

    Clinical Study of Cell Therapy for Disc Degeneration Clears Final Planned Safety Review

    3D-Printed Graftless Bone Transplants Go to Clinical Trials
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Sounding Board: Looking Back at 2019 and Gazing at 2020

    Molybdenum-Rhenium Biomaterial: Something ‘MoRe’?

    New Exoskeleton Shoulders Rehab Burden for Stroke Patients

    Repairing Knee Cartilage Defects with the Patient's Own Cells

    Compamed 2019 Preview Report
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Orthopedic Innovation Pty. Ltd.

    Oberg Medical

    Tecomet

    NN Life Sciences

    Donatelle
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10 Orthopedic Device Firms
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Columns

    Pace of Medtech M&A Activity Not Likely to Abate in 2017

    Pace of Medtech M&A Activity Not Likely to Abate in 2017
    The mergers and acquisitions of medtech OEMs and contract manufacturers last year progressed at a blistering pace, and it appears that rate could continue in 2017 barring any major political upheaval or unforeseen chaos.
    Related CONTENT
    • Kuros is Acquiring Xpand to Create Orthobiologics Firm
    • NuVasive to Resume XLIF Procedures in Japan in First Quarter
    • Fat-Derived Stem Cells Could Repair Shoulder Injuries
    • Philips' Augmented-Reality Navigation for Image-Guided Spine, Cranial, and Trauma Surgery
    • Integrated Endoscopy Appoints Chief Medical Officer, Advisory Board Chairman
    Mark Bonifacio, Founder and President, Bonifacio Consulting Services03.22.17
    Predicting the future can be risky and fraught with difficulty, especially in the healthcare sector. A myriad of unforeseen factors can affect outcomes, botching even the most conservative of forecasts.

    Some prophecies have better odds than others. Consider, for example, the consolidation that has reshaped the medical device sector over the last few years. Chances are good that this industry-wide condensation will continue this year as existing platforms, new private equity players, and sector-related strategies all vie for assets. The only uncertainty is the pace at which this activity will occur.

    From Trend to Norm
    The mergers and acquisitions of medtech OEMs and contract manufacturers (CMs) last year progressed at a blistering pace, and it appears that rate could continue in 2017, barring any major political upheaval or unforeseen chaos. The CM market in particular seems poised to continue this rapid pace of consolidation.

    Medtech industry executive Bill Ellerkamp detailed much of the recent activity in the medical device outsourcing market in his article in the January/February issue of MPO. Since that time—merely several weeks ago—Vention Medical closed its deal for Lithotech Medical, an Israeli-based developer of complex nitinol wire-based technologies [Editor’s Note: Vention has since been acquired itself.]; Ampersand Capital Partners made an undisclosed investment in Corpus Medical Inc., a Silicon Valley-based contract development and manufacturing organization focused on interventional medical devices, catheter-based delivery systems, and implants; and Medtronic plc is reportedly shopping around the Medical Supplies business it inherited with the blockbuster Covidien acquisition.

    The overall backdrop for these deals continues to remain strong. Low interest rates, deal leverage multiples, cash on private equity and strategic balance sheets, continued OEM consolidation, outside U.S. suppliers and investors looking for U.S. beachheads are all contributing to this high demand.

    Driving this consolidation is a highly fragmented space (especially when compared with automotive, aerospace, consumer, etc.), the need for some business sophistication for owners/operators and “mom and pop”-type operations, and perhaps most importantly, macro-economic pressure to reduce healthcare costs worldwide (with a particular focus in the United States, where overall healthcare gross domestic product spending approaches 18 percent).

    All of these factors point to more future deals. Stay tuned.

    Trade Stance Spurring Uncertainty
    One issue that may have significant repercussions on the medtech M&A market is the changing landscape on free trade and the trade agreements currently in place.

    The U.S. medical device industry is expected to remain highly competitive globally, partially due to national characteristics that allow companies to bring new and innovative technologies to market. The industry has increasingly embraced globalization, and an ever-growing number of multinational firms are aggressively pursuing markets around the world. These firms are focusing greater attention on international sales, joint ventures, mergers, and acquisitions. Global demand for medical devices is driven by rising expenditures and healthcare-related investments in developing markets through infrastructure (new hospitals and clinics), public health insurance, and an overall greater focus on health. In addition, global demand is likely to grow due to lifestyle diseases, aging populations in major markets, new and significant emerging markets, and rising global income levels in developing countries, according to a U.S. Department of Commerce report. Further, the worldwide convergence of standards and regulatory requirements should help facilitate global market growth and further trade opportunities. The medtech industry must not lose sight of this.

    America’s main global competition currently comes from Germany (Siemens AG and B. Braun), Japan (Hitachi Medical Corporation, Toshiba Medical Systems Corporation), and The Netherlands (Royal Philips). Notably because of its past and recent acquisitions, Philips currently produces more medical devices in the United States than in the European Union. While most projections show the United States maintaining its competitive advantage in the foreseeable future, international markets and low-cost device producers are expected to remain competitive, therefore giving America a run for her money.

    With the Trump administration ending the Trans-Pacific Partnership (TPP) and threatening to restructure the North American Free Trade Agreement (NAFTA), many multinational medtech firms and others that rely on these agreements remain on edge, since many of their strategic manufacturing models and current supply chain models rely on these agreements.

    The U.S. Commerce Department reports that trade between the United States and its NAFTA partners has soared since the agreement was enacted: U.S. goods exports to NAFTA partners have increased by almost 300 percent from 1993 to 2014, going from $142 billion to $552 billion during that time period. Moreover, U.S. trade with Canada and Mexico exceeds U.S. trade with the European Union and Japan combined. Federal statistics show that annual exports of U.S. medical devices to Canada have more than tripled since the year before NAFTA was signed into law, and exports of medtech products to Mexico have more than quadrupled.

    According to the Plastics Industry Association (PIA), NAFTA is responsible for 47.2 percent of the U.S. plastics industry’s $59.1 billion in global exports. The top three plastics exports markets are Mexico, Canada, and China, generating an overall trade surplus of nearly $39 billion. Plastics play a large role in many medical devices and single-use products.

    The TPP agreement removes tariffs on medical devices, supports increased regulatory coherence among member states, and widens stakeholder influence and transparency toward reimbursement and pricing. Ultimately, the TPP would have resulted in quicker approvals of medical devices, benefiting U.S. companies that export to signatory partner countries.

    Many trade organizations are now cautious as the nascent Trump administration looks to overhaul all or some of these agreements. Although I strongly believe these pacts can be improved, it is important for the president and Congress to consider the long-term impacts of nixing the TPP before making any final decisions. As the former owner and operator of a medical device CM that took advantage of NAFTA to supply high-value components to other NAFTA trade partners, I join the growing chorus of business folks urging the new administration to carefully consider all implications of upending or exiting these agreements. A hasty decision could jeopardize American leadership and rivalry in a globalized economy. 


    Mark Bonifacio is founder and president of Bonifacio Consulting Services LLC, a global consulting and advisory firm to medical device OEMs, contract manufacturers, private equity, and other investors in the medtech manufacturing sector. Bonifacio has a B.S. in plastics engineering from the University of Lowell (now UMASS-Lowell), and more than 25 years of experience in medical device manufacturing across many therapeutic disciplines and market segments. After working for major medical device OEMs, Bonifacio co-founded APEC, a Baldwin Park, Calif.-based contract manufacturer, and sold it to Helix Medical (now Freudenberg Medical) in 2007. He founded Bonifacio Consulting Services in 2008. BCS is headquartered in Boston, Mass., and has offices in California, Florida, and China.
    Related Searches
    • medical
    • development
    • medical devices
    • medtronic plc
    Suggested For You
    Tegra Medical Tegra Medical
    Criterion Instrument Criterion Instrument
    What’s New in Orthopedics in the ED? What’s New in Orthopedics in the ED?
    LaVezzi Precision, Inc. LaVezzi Precision, Inc.
    Bioness L300 Go Rehab System Wins CE Mark Bioness L300 Go Rehab System Wins CE Mark
    Australian Regulators Approve Stimwave Australian Regulators Approve Stimwave's Freedom Spinal Cord Stimulation System
    Rotation Medical President and CEO Appointed to AdvaMed Board Rotation Medical President and CEO Appointed to AdvaMed Board
    Testing Your Patience Testing Your Patience
    ASTM Guide Supports Cleaning Protocols for Reusable Medical Devices ASTM Guide Supports Cleaning Protocols for Reusable Medical Devices
    AAOS: Tissue Regenix Introduces dCELL Platform Technology to the United States AAOS: Tissue Regenix Introduces dCELL Platform Technology to the United States
    RAMD 2017: The World Congress on Regulatory Affairs for Medical Devices RAMD 2017: The World Congress on Regulatory Affairs for Medical Devices
    Synergy Biomedical Awarded CE Mark for BioSphere Putty Synergy Biomedical Awarded CE Mark for BioSphere Putty
    The Benefits of Electronic Medical Device Reporting The Benefits of Electronic Medical Device Reporting
    Alphatec Spine Replaces Resigning Board Member Alphatec Spine Replaces Resigning Board Member
    Zimmer Biomet Internationally Launches Subchondroplasty Procedure Zimmer Biomet Internationally Launches Subchondroplasty Procedure

    Related Columns

    • Extremities
      Toe Fusion Alternatives Gaining a Firm Market Foothold

      Toe Fusion Alternatives Gaining a Firm Market Foothold

      Dr. Carl Hasselman, co-designer of the Arthrosurface ToeMotion Arthroplasty System, speaks about non-fusion alternatives for MTPJ osteoarthritis.
      Michael Barbella, Managing Editor 12.02.19

    • The Cluster Effect in Orthopedics: Is It Sustainable?

      The Cluster Effect in Orthopedics: Is It Sustainable?

      For a long time, we all assumed Minnesota dominated the medical device industry worldwide, but is this true for the orthopedic surgical tools industry?
      Maria Shepherd, President and Founder, Medi-Vantage 12.02.19

    • ‘If You’re Reading This, You Need to Be at This Meeting’

      ‘If You’re Reading This, You Need to Be at This Meeting’

      The AAOS/FDA/Industry Townhall is taking place March 24, 2020, at the AAOS annual meeting in Orlando.
      Dawn A. Lissy, President & Founder, Empirical 12.02.19


    • Turning the New EU MDR Into a Competitive Advantage

      Turning the New EU MDR Into a Competitive Advantage

      This column examines three new elements of the EU MDR that medical device manufacturers can leverage.
      Dan Goldstein, Associate Director, Quality Assurance, MCRA LLC 12.02.19

    • Design | Large Joint | Spine/Neurology
      Five Reasons for the Small World of Orthopedic Product Development

      Five Reasons for the Small World of Orthopedic Product Development

      Why do product development people tend to stay within the orthopedic and spine industry and not cross over into other medtech sectors?
      Victoria Trafka, BSME, MSME, President and Lead Engineer, Engineering & Quality Solutions Inc. 12.02.19

    • Impeachment, Executive Orders, and Must-Pass Congressional Legislation: A Fall Update

      Impeachment, Executive Orders, and Must-Pass Congressional Legislation: A Fall Update

      The final quarter of 2019 has begun, which means Congress and the Trump Administration are hard at work finalizing healthcare initiatives before year's end.
      Jeffrey J. Kimbell, David C. Rudloff, and Caroline P. Tucker, Jeffrey J. Kimbell & Associates Inc. 12.02.19


    • Spine/Neurology
      Pediatric Orthopedics Taken Off the Back Burner

      Pediatric Orthopedics Taken Off the Back Burner

      There are several different types of scoliosis, a condition that causes a sideways spinal curve, that affect children and adolescents.
      Sam Brusco, Associate Editor 09.17.19

    • What Are Orthopedic Surgeon Salary and Employment Statistics?

      What Are Orthopedic Surgeon Salary and Employment Statistics?

      The percent of employed physicians is greater than self-employed physicians.
      Maria Shepherd, President and Founder, Medi-Vantage 09.17.19

    • U.S. May Offer a Safe Harbor from the Impending MDR Storm

      U.S. May Offer a Safe Harbor from the Impending MDR Storm

      There are factors that make for a more inviting environment for the medical device industry in the United States.
      Dawn A. Lissy, President & Founder, Empirical 09.17.19


    • How Identifying Gaps in Clinical Data Can Ease the Transition to New Regulations

      How Identifying Gaps in Clinical Data Can Ease the Transition to New Regulations

      As of 2017, the European medical device market was estimated  at $126 billion, the second largest worldwide, comprising 27 percent of the global market. The European market trails only the United States, which accounts for roughly 43 percent of…
      Mike Goodson, Associate Director, Regulatory Affairs, MCRA LLC 09.17.19

    • Software & Quality
      Benefiting from Paperless Production Records: A Case Study

      Benefiting from Paperless Production Records: A Case Study

      EpiBone discovered how eliminating paper with digital production records can help ensure data integrity, reduce errors, and increase efficiency.
      Terrance Holbrook, Director of Product, MasterControl 09.17.19

    • Connecting the Dots in Medical Device Outsourcing

      Connecting the Dots in Medical Device Outsourcing

      San Francisco is globally renowned for many things: The Golden Gate Bridge (its color, international orange, was actually a primer used to protect the steel during transit), Ghirardelli chocolate, the TransAmerica pyramid building, and the “Pai…
      ODT Staff 08.14.19

    • What Keeps Hospital CEOs Awake at Night and How Can Medtech Help?

      What Keeps Hospital CEOs Awake at Night and How Can Medtech Help?

      With the continued surge of mergers and acquisitions, vertical integrations, and no clear U.S. policy or reform direction for our $3.6 trillion annual healthcare spend,1 the healthcare ecosystem remains in a phase of dramatic disruption. What Is K…
      Maria Shepherd, President and Founder, Medi-Vantage 08.14.19

    • Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry

      Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry

      I’m generally an optimistic person. My outgoing voicemail greeting encourages every caller to “keep smiling!” My wardrobe is about 40 percent “Life is Good” apparel and I keep a daily gratitude journal. Despite this s…
      Dawn A. Lissy, President & Founder, Empirical 08.14.19

    • Successful Strategies for Health Plan Medical Policy Outreach

      Successful Strategies for Health Plan Medical Policy Outreach

      Getting approval from the FDA can be a significant achievement for a company but a bigger challenge awaits for novel technologies: health payor acceptance and coverage. Adopting a novel technology does not occur easily due to complex commercial insur…
      Chelsey Jaworski and Anabel Tapia, MCRA 08.14.19


    Breaking News
    • TriMed Closes Out FDA Warning Letter
    • FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System
    • OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application
    • Tyber Medical Opens $8M Office and Manufacturing Facility
    • FDA OKs Shoulder Surgery 3D Planner & Positioner
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • From Nitinol to Nanotubes: A Materials Science Roundtable
    • In Good Repair: Trauma Technologies Under Review
    • Anxious Undertones: A Review of 2019
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Beckers Group Announces Global Price Increase on Coil, Industrial Coatings
    Evonik, Wynca Celebrate Groundbreaking of New Fumed Silica Plant in Zhenjiang
    Personnel Changes in Corporate Communications, Government Relations at BASF
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    15-Year Tele-Critical Care Collabration Yields Significant ICU Improvement Results
    Prellis Biologics' New Tool Simplifies Complex Tissue Engineering
    InspireMD's CEO Steps Down
    Contract Pharma

    Latest Breaking News From Contract Pharma

    CatSci Expands Capabilities with Lab Expansion
    Smart Tags on Pills Set to Improve Supply Chain Security and Patient Adherence
    PCI Pharma Services Invests in Tredegar, UK Site
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Star of E!'s Botched Gets Line Leaping Bunny Certified
    Happi

    Latest Breaking News From Happi

    Birchbox Partners with Buzzfeed
    Coty Strengthens Its Leadership
    Jennifer Garner Joins Virtue Labs
    Ink World

    Latest Breaking News From Ink World

    Smurfit Kappa, Wings for Aid Create Disaster Relief Packaging Solution
    ePac Flexible Packaging Expands into Asia Pacific Market
    United Carton Industries Company Invests in EFI Nozomi Corrugated Printer
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Mark Andy joins forces with UPM Raflatac
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Simavita Set to License Sensor Technology in EU
    NDC Appoints President
    AATC Adds Two Scholarships
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    TriMed Closes Out FDA Warning Letter
    FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System
    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI Releases Global Semiconductor Equipment Sales Forecast
    eMagin Corporation Announces Approximately $4.3 Million Order for Military Program
    CPI Supports Smart Food-labeling Project Set to Reduce Food Waste in 2020

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.